Last quarter (Q3 2025), Urogen Pharma's total revenue was $27.48M, an increase of 9.04% from the same quarter last year. In Q3, Urogen Pharma's net income was $-33.35M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 90.40M	$ 82.71M	$ 64.36M	$ 48.04M	$ 11.80M
Gross Profit	$ 81.52M	$ 73.35M	$ 56.70M	$ 42.88M	$ 10.79M
Operating Expenses	$ 178.30M	$ 138.89M	$ 135.74M	$ 135.18M	$ 137.53M
Depreciation and Amortization	$ 329.00K	$ 1.71M	$ 1.82M	$ 831.00K	$ 2.04M
EBITDA	$ -95.35M	$ -60.35M	$ -76.21M	$ -91.46M	$ -122.71M
Operating Income	$ -96.78M	$ -65.54M	$ -79.04M	$ -92.29M	$ -126.74M
Other Income/Expenses	$ -27.26M	$ -32.79M	$ -28.99M	$ -17.08M	$ 1.63M
Pretax Income	$ -124.04M	$ -98.32M	$ -108.03M	$ -109.37M	$ -125.11M
Net Income	$ -126.87M	$ -102.24M	$ -109.78M	$ -110.82M	$ -128.48M
Per Share Metrics
Basic EPS	$ -2.96	$ -3.55	$ -4.79	$ -4.96	$ -5.90
Diluted EPS	$ -2.96	$ -3.55	$ -4.79	$ -4.96	$ -5.90
Weighted Average Shares Outstanding	42.88M	28.83M	22.81M	22.35M	21.78M
Weighted Average Shares Outstanding (Diluted)	42.88M	28.83M	22.81M	22.35M	21.78M

Currency in USD

Urogen Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing